Literature DB >> 7505205

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

T Suda1, T Takahashi, P Golstein, S Nagata.   

Abstract

The Fas antigen (Fas) belongs to the tumor necrosis factor (TNF)/nerve growth factor receptor family, and it mediates apoptosis. Using a soluble form of mouse Fas, prepared by fusion with human immunoglobulin Fc, Fas ligand was detected on the cell surface of a cytotoxic T cell hybridoma, PC60-d10S. A cell population that highly expresses Fas ligand was sorted using a fluorescence-activated cell sorter, and its cDNA was isolated from the sorted cells by expression cloning. The amino acid sequence indicated that Fas ligand is a type II transmembrane protein that belongs to the TNF family. The recombinant Fas ligand expressed in COS cells induced apoptosis in Fas-expressing target cells. Northern hybridization revealed that Fas ligand is expressed in activated splenocytes and thymocytes, consistent with its involvement in T cell-mediated cytotoxicity and in several nonlymphoid tissues, such as testis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505205     DOI: 10.1016/0092-8674(93)90326-l

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  439 in total

1.  LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death.

Authors:  N V Somia; M J Schmitt; D E Vetter; D Van Antwerp; S F Heinemann; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.

Authors:  T H Holmström; I Schmitz; T S Söderström; M Poukkula; V L Johnson; S C Chow; P H Krammer; J E Eriksson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

Review 3.  Molecular steps of cell suicide: an insight into immune senescence.

Authors:  S Gupta
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

4.  Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community.

Authors:  D J Hetmanski; N J Sparrow; S Curtis; A J Cowley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

5.  Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Authors:  J L Cracowski; F Tremel; C Marpeau; J P Baguet; F Stanke-Labesque; J M Mallion; G Bessard
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

6.  Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.

Authors:  D Skudicky; K Sliwa; A Bergemann; G Candy; P Sareli
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

7.  Relation between circulating soluble Fas ligand and subsequent ventricular remodelling following myocardial infarction.

Authors:  T Soeki; Y Tamura; H Shinohara; K Sakabe; Y Onose; N Fukuda
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

8.  Autologous killing by a population of intermediate T-cell receptor cells and its NK1.1+ and NK1.1- subsets, using Fas ligand/Fas molecules.

Authors:  T Moroda; T Iiai; S Suzuki; A Tsukahara; T Tada; M Nose; K Hatakeyama; S Seki; K Takeda; H Watanabe; T Abo
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

9.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

10.  Frequent Fas gene mutations in testicular germ cell tumors.

Authors:  Hitoshi Takayama; Tetsuya Takakuwa; Yuichi Tsujimoto; Yoichi Tani; Norio Nonomura; Akihiko Okuyama; Shigekazu Nagata; Katsuyuki Aozasa
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.